The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-bound Peptide-flanking Residues
Overview
Authors
Affiliations
Peptides bind to MHC class II molecules with a defined periodicity such that the peptide-flanking residues (PFRs) P-1 and P11, which lie outside the core binding sequence (P1-P9), are solvent exposed and accessible to the TCR. Using a novel MHC class II:peptide binding assay, we defined the binding register for nine immunogenic epitopes to formally identify the flanking residues. Seven of the nine epitopes, restricted by H-2A(k), H-2A(g7), or H-2E(k), were found to generate T cells that were completely dependent on either P-1 or P11, with dependency on P-1 favored over P11. Such PFR dependency appears to be influenced by the type of amino acid exposed, in that residues that can form salt bridges or hydrogen bonds are favored over small or hydrophobic residues. Peptides containing alanine substitutions at P-1 or P11 in place of PFRs that mediate dependency were considerably less immunogenic and mediated a substantially reduced in vitro recall response to the native protein, inferring that PFR recognition increases immunogenicity. Our data suggest that PFR recognition is a common event characteristic of all MHC class II-restricted T cell responses. This key feature, which is not shared by MHC class I-restricted responses, may underlie the broad functional diversity displayed by MHC class II-restricted T cells.
Geometric deep learning improves generalizability of MHC-bound peptide predictions.
Marzella D, Crocioni G, Radusinovic T, Lepikhov D, Severin H, Bodor D Commun Biol. 2024; 7(1):1661.
PMID: 39702482 PMC: 11659464. DOI: 10.1038/s42003-024-07292-1.
Energy landscapes of peptide-MHC binding.
Collesano L, Luksza M, Lassig M PLoS Comput Biol. 2024; 20(9):e1012380.
PMID: 39226310 PMC: 11398667. DOI: 10.1371/journal.pcbi.1012380.
Hartman K, Steiner G, Siegel M, Looney C, Hickling T, Bray-French K Biology (Basel). 2023; 12(9).
PMID: 37759665 PMC: 10525474. DOI: 10.3390/biology12091265.
Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota.
Wen M, Li Y, Qin X, Qin B, Wang Q Cells. 2023; 12(14).
PMID: 37508545 PMC: 10378520. DOI: 10.3390/cells12141882.
Panni U, Chen M, Zhang F, Cullinan D, Li L, James C Cancer Immunol Immunother. 2023; 72(8):2813-2827.
PMID: 37179276 PMC: 10361914. DOI: 10.1007/s00262-023-03463-x.